Radiomics of the Airway (RadAr): Multi-Scale Airway Phenotyping for Disease Characterization on Routine CT Imaging
Preprint
Abstract
Background: Airway remodeling is a convergent feature across respiratory diseases, yet current quantitative CT tools quantify a small number of prespecified structural abnormalities of the airway tree. Radiomics of the Airway (RadAr) derives interpretable, multi-scale airway measurements from chest CT to characterize airway deformation and discover quantitative imaging biomarkers from routine chest CT. Methods: RadAr extracts over 400 multi-scale, interpretable airway measurements across lobes or generations capturing luminal dimensions, tapering, architectural distortion, and global morphology. It was evaluated in N=1331 patients across four settings: 63-week mortality prediction in fibrotic interstitial lung disease (fILD), COVID-19 severity prediction, structure-function association in progressive pulmonary fibrosis (PPF) and structure-inflammation markers in pediatric cystic fibrosis (CF). Unsupervised clustering was used to identify airway phenotypes across the fILD and COVID-19 cohorts. Results: In fILD, lower-lobe architectural distortion was associated with mortality (balanced accuracy 0·654). In COVID-19, severe disease was independently associated with luminal dilation (AUC 0·719, odds ratio 2·32, p=0·017). In PPF, airway phenotypes correlated with forced vital capacity (ρ=0·83), mid-expiratory flow (ρ=0·87), and ¹²⁹Xe MRI alveolar gas exchange impairment (ρ=0·70). In pediatric CF, reduced tapering and increased cylindricity were associated with prior exacerbations and bronchoalveolar lavage neutrophilia (ρ=-0·64 to -0·78). Five phenotypes were identified from extensive, tapered airway trees to sparse, dilated, thick-walled, tortuous trees, with increasing COVID-19 severity and fILD mortality across this spectrum. Conclusion: RadAr identified interpretable, disease-specific airway phenotypes associated with function and outcomes across restrictive, obstructive, and mixed lung diseases in adult and pediatric settings. These findings establish a framework for discovery and development of quantitative airway biomarkers for patient stratification, disease monitoring, or imaging endpoint development in pulmonary trials.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL158071 - 01A1)
- National Institute of Allergy and Infectious Diseases (R01AI175555 - 01A1)
- National Institute of Allergy and Infectious Diseases (R01HL151277 - 01A1)
- National Institute of Biomedical Imaging and Bioengineering (75N92022D00015)
- U.S. National Library of Medicine (R01LM013864 - 01A1)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK118431)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK133090 - 01)
- U.S. Department of Veterans Affairs (IBX004121)
- VA Biomedical Laboratory Research and Development Service (IK6BX006185)
- Office of Research and Development (LPOP-L0021)
- Fund for Innovation in Cancer Informatics
- Institute for Technology in Healthcare
- Scott MacKenzie Foundation
This publication has 37 references indexed in Scilit:
- Immune Checkpoint Inhibitors and Interstitial Lung Disease: A Comprehensive Review of Pathogenesis, Diagnosis, and ManagementOpen Respiratory Archives, 2026
- Hunting imaging biomarkers in pulmonary fibrosis: Benchmarks of the AIIB23 challengeMedical Image Analysis, 2024
- Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CFJournal of Cystic Fibrosis, 2024
- Cystic fibrosis modulator therapy can reverse cystic bronchiectasisRespirology Case Reports, 2023
- Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2‐year‐olds with cystic fibrosisPediatric Pulmonology, 2022
- Airway tapering: an objective image biomarker for bronchiectasisEuropean Radiology, 2020
- Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: The potential risk of extensive radiation pneumonitisLung Cancer, 2013
- Vascular tortuosity: a mathematical modeling perspectiveThe Journal of Physiological Sciences, 2012
- Robust Statistics2011
- Endpoints in respiratory diseasesEuropean Journal of Clinical Pharmacology, 2010